David Berz

1.9k citations
58 papers · 1.5k · h-index 19

Impact in

Papers in

    • Cancer Immunotherapy and Biomarkers 10
    • Colorectal Cancer Treatments and Studies 2
    • Cancer-related Molecular Pathways 2
    • Lung Cancer Treatments and Mutations 14
    • Lung Cancer Diagnosis and Treatment 3
    • Advanced Breast Cancer Therapies 2

David Berz

56 papers receiving 1.4k citations

Peers

David Berz
Comparison fields: 5 of 78
  • Cancer Research 258
  • Hematology 190
  • Pulmonary and Respiratory Medicine 357
  • Oncology 209
  • Genetics 72
Replace Binglin Yue with:
Binglin Yue United States
Wen Gao China
Mikhail I. Shtivelband United States
Trilok V. Parekh United States
Hiroya Oka Japan
Lionel A. D'Hondt Belgium
Patrick J. Ward United States
Giuliana Cavalloni Italy
Christopher Ruel United States
Yoshiyasu Nakamura Japan
David Berz relative to Binglin Yue United States Binglin Yue's profile →
Citations per field
00.5×2×3.1×
Binglin Yue · 1×
Citations per year

Countries citing papers authored by David Berz

Since Specialization
Citations

This map shows the geographic impact of David Berz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Berz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Berz more than expected).

Fields of papers citing papers by David Berz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Berz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Berz. The network helps show where David Berz may publish in the future.

Co-authors

The 25 scholars most cited alongside David Berz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Berz Line = papers co-authored together David Berz links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2016258
2 2007207
3 2010184
4 2020127
5 200962
6 201750
7 202047
8 200845
9 202338
10 202329
11 201128
12 201124
13 201724
14 201824
15 202524
16 201322
17 201321
18 201119
19 202119
20 201518

About David Berz

David Berz is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Hematology, Pathology and Forensic Medicine and Cancer Research, having authored 58 papers that have together received 1.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (14 papers), Cancer Immunotherapy and Biomarkers (10 papers), Hematopoietic Stem Cell Transplantation (5 papers), Lung Cancer Diagnosis and Treatment (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Advanced Breast Cancer Therapies (2 papers), Colorectal Cancer Treatments and Studies (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Cancer Research (258 citations), Hematology (190 citations), Pulmonary and Respiratory Medicine (357 citations), Oncology (209 citations) and Genetics (72 citations). David Berz has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Gerald A. Colvin, Peter J. Quesenberry, Eric S. Winer, Elise M. McCormack, Mark S. Dooner, Douglas C. Hixson, Bharat Ramratnam, Harold J. Wanebo, Jason M. Aliotta and Carol A. Ayala. Their work appears in journals such as Annals of Oncology, Journal of Thoracic Oncology, Blood, Journal of Clinical Oncology and Experimental Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact